Interventional Studies for Polycystic Ovarian Syndrome in Children and Adolescents

• Blank SK , HelmKD, McCartneyCR, MarshallJC: Polycystic ovary syndrome in adolescence.Ann. NY Acad. Sci.1135, 76–84(2008).
   PubMed Web of Science ®Google Scholar
• Rosenfield RL : What every physician should know about polycystic ovary syndrome.Dermatol. Ther.21, 354–361(2008).
   PubMed Web of Science ®Google Scholar
• Harwood K , VuguinP, DiMartino-NardiJ: Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth.Horm. Res.68, 209–217(2007).
   PubMed Web of Science ®Google Scholar
• Knochenhauer ES , KeyTJ, Kahsar-MillerM, WaggonerW, BootsLR, AzzizR: Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.J. Clin. Endocrinol. Metab.83, 3078–3082(1998).
   PubMed Web of Science ®Google Scholar
• Azziz R , CarminaE, DewaillyDet al.: The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.Fertil. Steril.91, 456–488(2009).
   PubMed Web of Science ®Google Scholar
• Zawadski JK , DunaifA: Diagnostic Criteria for Polycystic Ovary Syndrome; Towards a Rational Approach. Blackwell Scientific, MA, USA (1992).
   Google Scholar
• Legro RS , KunselmanAR, DodsonWC, DunaifA: Prevalence and predictors of risk for Type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.J. Clin. Endocrinol. Metab.84, 165–169(1999).
   PubMed Web of Science ®Google Scholar
• Ehrmann DA , BarnesRB, RosenfieldRL, CavaghanMK, ImperialJ: Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.Diabetes Care22, 141–146(1999).
   PubMed Web of Science ®Google Scholar
• Azziz R , CarminaE, DewaillyDet al.: Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.J. Clin. Endocrinol. Metab.91, 4237–4245(2006).
   PubMed Web of Science ®Google Scholar
• Franks S : Polycystic ovary syndrome in adolescents.Int. J. Obes. (Lond.)32, 1035–1041(2008).
   PubMed Web of Science ®Google Scholar
• van Hooff MH , VoorhorstFJ, KapteinMB, HirasingRA, KoppenaalC, SchoemakerJ: Endocrine features of polycystic ovary syndrome in a random population sample of 14–16 year old adolescents.Hum. Reprod.14, 2223–2229(1999).
   PubMed Web of Science ®Google Scholar
• Dramusic V , RajanU, ChanP, RatnamSS, WongYC: Adolescent polycystic ovary syndrome.Ann. NY Acad. Sci.816, 194–208(1997).
   PubMed Web of Science ®Google Scholar
• Witchel SF : Puberty and polycystic ovary syndrome.Mol. Cell. Endocrinol.254–255, 146–153(2006).
   PubMed Web of Science ®Google Scholar
• Sultan C , ParisF: Clinical expression of polycystic ovary syndrome in adolescent girls.Fertil. Steril.86(Suppl. 1), S6 (2006).
   PubMed Web of Science ®Google Scholar
• Goodarzi MO , AzzizR: Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.Best Pract. Res. Clin. Endocrinol. Metab.20, 193–205(2006).
   PubMed Web of Science ®Google Scholar
• Warren-Ulanch J , ArslanianS: Treatment of PCOS in adolescence.Best Pract. Res. Clin. Endocrinol. Metab.20, 311–330(2006).
   PubMed Web of Science ®Google Scholar
• Tracy Bekx M , ConnorEC, AllenDB: Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome.J. Pediatr. Adolesc. Gynecol. (2009) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Nader S : Adrenarche and polycystic ovary syndrome: a tale of two hypotheses.J. Pediatr. Adolesc. Gynecol.20, 353–360(2007).
   PubMed Web of Science ®Google Scholar
• DiMartino-Nardi J : Pre- and postpuberal findings in premature adrenarche.J. Pediatr. Endocrinol. Metab.13(Suppl. 5), 1265–1269(2000).
   PubMed Web of Science ®Google Scholar
• Vuguin P , GrinsteinG, FreemanK, SaengerP, DiMartino Nardi J: Prediction models for insulin resistance in girls with premature adrenarche. The premature adrenarche insulin resistance score: PAIR score. Horm. Res.65, 185–191(2006).
   PubMedGoogle Scholar
• Rieder J , SantoroN, CohenHW, MarantzP, CoupeySM: Body shape and size and insulin resistance as early clinical predictors of hyperandrogenic anovulation in ethnic minority adolescent girls.J. Adolesc. Health43, 115–124(2008).
   PubMed Web of Science ®Google Scholar
• Rosenfield RL : Clinical review: identifying children at risk for polycystic ovary syndrome.J. Clin. Endocrinol. Metab.92, 787–796(2007).
   PubMed Web of Science ®Google Scholar
• Tfayli H , ArslanianS: Menstrual health and the metabolic syndrome in adolescents.Ann. NY Acad. Sci.1135, 85–94(2008).
   PubMed Web of Science ®Google Scholar
• Legro RS , DriscollD, StraussJF 3rd, Fox J, Dunaif A: Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc. Natl Acad. Sci. USA95, 14956–14960(1998).
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T , CodnerE, PerezVet al.: Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.J. Clin. Endocrinol. Metab.94, 1923–1930(2009).
   PubMed Web of Science ®Google Scholar
• Pagan YL , SroujiSS, JimenezY, EmersonA, GillS, HallJE: Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.J. Clin. Endocrinol. Metab.91, 1309–1316(2006).
   PubMed Web of Science ®Google Scholar
• McNatty KP , MakrisA, DeGraziaC, OsathanondhR, RyanKJ: The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro.J. Clin. Endocrinol. Metab.49, 687–699(1979).
   PubMed Web of Science ®Google Scholar
• Blank SK , McCartneyCR, MarshallJC: The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.Hum. Reprod. Update12, 351–361(2006).
   PubMed Web of Science ®Google Scholar
• Taylor AE , McCourtB, MartinKAet al.: Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.J. Clin. Endocrinol. Metab.82, 2248–2256(1997).
   PubMed Web of Science ®Google Scholar
• Kasa-Vubu JZ , JainV, WelchK: Impact of fatness, insulin, and gynecological age on luteinizing hormone secretory dynamics in adolescent females.Fertil. Steril. doi:10.1016/j.fertnstert.2009.02.072 (2009) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Berga SL , GuzickDS, WintersSJ: Increased luteinizing hormone and α-subunit secretion in women with hyperandrogenic anovulation.J. Clin. Endocrinol. Metab.77, 895–901(1993).
   PubMed Web of Science ®Google Scholar
• Eagleson CA , GingrichMB, PastorCLet al.: Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.J. Clin. Endocrinol. Metab.85, 4047–4052(2000).
   PubMed Web of Science ®Google Scholar
• Turgeon JL , WaringDW: Androgen modulation of luteinizing hormone secretion by female rat gonadotropes.Endocrinology140, 1767–1774(1999).
   PubMed Web of Science ®Google Scholar
• Blank SK , McCartneyCR, ChhabraSet al.: Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls – implications for regulation of pubertal maturation.J. Clin. Endocrinol. Metab.94, 2360–2366(2009).
   PubMed Web of Science ®Google Scholar
• Ehrmann DA : Polycystic ovary syndrome.N. Engl. J. Med.352, 1223–1236(2005).
   PubMed Web of Science ®Google Scholar
• Franks S , Gilling-SmithC, WatsonH, WillisD: Insulin action in the normal and polycystic ovary.Endocrinol. Metab. Clin. North Am.28, 361–378(1999).
   PubMed Web of Science ®Google Scholar
• Nestler JE , JakubowiczDJ, de Vargas AF, Brik C, Quintero N, Medina F: Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J. Clin. Endocrinol. Metab.83, 2001–2005(1998).
   PubMed Web of Science ®Google Scholar
• Magoffin D : Ovarian Steroidogenic Abnormalities in the Polycystic Ovary Syndrome Humana Press, NY, USA (2007).
   Google Scholar
• Buggs C , RosenfieldRL: Polycystic ovary syndrome in adolescence.Endocrinol. Metab. Clin. North Am.34, 677–705(2005).
   PubMed Web of Science ®Google Scholar
• Longcope C : Adrenal and gonadal androgen secretion in normal females.Clin. Endocrinol. Metab.15, 213–228(1986).
   PubMedGoogle Scholar
• Sorensen K , AksglaedeL, Munch-AndersenTet al.: Sex hormone-binding globulin levels predict insulin sensitivity, disposition index, and cardiovascular risk during puberty.Diabetes Care32, 909–914(2009).
   PubMed Web of Science ®Google Scholar
• Bridges NA , CookeA, HealyMJ, HindmarshPC, BrookCG: Standards for ovarian volume in childhood and puberty.Fertil. Steril.60, 456–460(1993).
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E , ChristakouC, PaliouraE, KandarakiE, LivadasS: Does polycystic ovary syndrome start in childhood?Pediatr. Endocrinol. Rev.5, 904–911(2008).
   PubMedGoogle Scholar
• Guttmann-Bauman I : Approach to adolescent polycystic ovary syndrome (PCOS) in the pediatric endocrine community in the U.S.A.J. Pediatr. Endocrinol. Metab.18, 499–506(2005).
   PubMed Web of Science ®Google Scholar
• Medicine PC otASfR: Current evaluation of amenorrhea. Fertil. Steril.82, S33–S39 (2004).
   PubMedGoogle Scholar
• Franks S : Adult polycystic ovary syndrome begins in childhood.Best Pract. Res. Clin. Endocrinol. Metab.16, 263–272(2002).
   PubMed Web of Science ®Google Scholar
• Rachmiel M , KivesS, AtenafuE, HamiltonJ: Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents: a unique subgroup?Arch. Pediatr. Adolesc. Med.162, 521–525(2008).
   PubMedGoogle Scholar
• Winters SJ , TalbottE, GuzickDS, ZborowskiJ, McHughKP: Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome.Fertil. Steril.73, 724–729(2000).
   PubMed Web of Science ®Google Scholar
• DeUgarte CM , WoodsKS, BartolucciAA, AzzizR: Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism.J. Clin. Endocrinol. Metab.91, 1345–1350(2006).
   PubMed Web of Science ®Google Scholar
• Wijeyaratne CN , BalenAH, BarthJH, BelchetzPE: Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?Clin. Endocrinol. (Oxf.)57, 343–350(2002).
   PubMed Web of Science ®Google Scholar
• Ferriman D , GallweyJD: Clinical assessment of body hair growth in women.J. Clin. Endocrinol. Metab.21, 1440–1447(1961).
   PubMed Web of Science ®Google Scholar
• Yildiz BO , BolourS, WoodsK, MooreA, AzzizR: Visually scoring hirsutism.Hum. Reprod. Update16(1), 51–64(2010).
   PubMed Web of Science ®Google Scholar
• Galobardes B , Davey Smith G, Jefferys M, McCarron P: Has acne increased? Prevalence of acne history among university students between 1948 and 1968. The Glasgow Alumni Cohort Study. Br. J. Dermatol.152, 824–825(2005).
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF , AsuncionM, CalvoRM, SanchoJ, San Millan JL: Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur. J. Endocrinol.145, 619–624(2001).
   PubMed Web of Science ®Google Scholar
• Azziz R , FoxLM, ZacurHA, ParkerCR Jr, Boots LR: Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin. J. Clin. Endocrinol. Metab.86, 2513–2517(2001).
   PubMed Web of Science ®Google Scholar
• Puurunen J , PiltonenT, JaakkolaP, RuokonenA, Morin-PapunenL, TapanainenJS: Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.J. Clin. Endocrinol. Metab.94, 1973–1978(2009).
   PubMed Web of Science ®Google Scholar
• Lobo RA , PaulWL, GoebelsmannU: Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function.Obstet. Gynecol.57, 69–73(1981).
   PubMed Web of Science ®Google Scholar
• Ehrmann DA , RosenfieldRL, BarnesRB, BrigellDF, SheikhZ: Detection of functional ovarian hyperandrogenism in women with androgen excess.N. Engl. J. Med.327, 157–162(1992).
   PubMed Web of Science ®Google Scholar
• Michelmore KF , BalenAH, DungerDB, VesseyMP: Polycystic ovaries and associated clinical and biochemical features in young women.Clin. Endocrinol. (Oxf.)51, 779–786(1999).
   PubMed Web of Science ®Google Scholar
• Polson DW , AdamsJ, WadsworthJ, FranksS: Polycystic ovaries – a common finding in normal women.Lancet1, 870–872(1988).
   PubMed Web of Science ®Google Scholar
• Farquhar CM , BirdsallM, ManningP, MitchellJM: Transabdominal versus transvaginal ultrasound in the diagnosis of polycystic ovaries in a population of randomly selected women.Ultrasound Obstet. Gynecol.4, 54–59(1994).
   PubMed Web of Science ®Google Scholar
• Mortensen M , EhrmannDA, LittlejohnE, RosenfieldRL: Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population.J. Clin. Endocrinol. Metab.94, 1579–1586(2009).
   PubMed Web of Science ®Google Scholar
• Block E : A quantitative morphological investigation of the follicular system in newborn female infants.Acta Anat. (Basel)17, 201–206(1953).
   PubMedGoogle Scholar
• Baker TG : A quantitative and cytological study of germ cells in human ovaries.Proc. R Soc. Lond. B Biol. Sci.158, 417–433(1963).
   PubMed Web of Science ®Google Scholar
• Mortensen M , RosenfieldRL, LittlejohnE: Functional significance of polycystic-size ovaries in healthy adolescents.J. Clin. Endocrinol. Metab.91, 3786–3790(2006).
   PubMed Web of Science ®Google Scholar
• Arroyo A , LaughlinGA, MoralesAJ, YenSS: Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.J. Clin. Endocrinol. Metab.82, 3728–3733(1997).
   PubMed Web of Science ®Google Scholar
• Homburg R : What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome.Hum. Reprod.17, 2495–2499(2002).
   PubMed Web of Science ®Google Scholar
• Morales AJ , LaughlinGA, ButzowT, MaheshwariH, BaumannG, YenSS: Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.J. Clin. Endocrinol. Metab.81, 2854–2864(1996).
   PubMed Web of Science ®Google Scholar
• Conway GS , HonourJW, JacobsHS: Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients.Clin. Endocrinol. (Oxf.)30, 459–470(1989).
   PubMed Web of Science ®Google Scholar
• Grundy SM , CleemanJI, DanielsSRet al.: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.Circulation112, 2735–2752(2005).
   PubMed Web of Science ®Google Scholar
• Cook S , AuingerP, LiC, FordES: Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey 1999–2002.J. Pediatr.152, 165–170(2008).
   PubMed Web of Science ®Google Scholar
• Zimmet P , AlbertiG, KaufmanFet al.: The metabolic syndrome in children and adolescents.Lancet369, 2059–2061(2007).
   PubMed Web of Science ®Google Scholar
• de Ferranti SD , GauvreauK, LudwigDS, NeufeldEJ, NewburgerJW, RifaiN: Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.Circulation110, 2494–2497(2004).
   PubMed Web of Science ®Google Scholar
• Salley KE , WickhamEP, CheangKI, EssahPA, KarjaneNW, NestlerJE: Glucose intolerance in polycystic ovary syndrome – a position statement of the Androgen Excess Society.J. Clin. Endocrinol. Metab.92, 4546–4556(2007).
   PubMed Web of Science ®Google Scholar
• Coviello AD , LegroRS, DunaifA: Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.J. Clin. Endocrinol. Metab.91, 492–497(2006).
   PubMed Web of Science ®Google Scholar
• Leibel NI , BaumannEE, KocherginskyM, RosenfieldRL: Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome.J. Clin. Endocrinol. Metab.91, 1275–1283(2006).
   PubMed Web of Science ®Google Scholar
• Lewy VD , DanadianK, WitchelSF, ArslanianS: Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.J. Pediatr.138, 38–44(2001).
   PubMed Web of Science ®Google Scholar
• Rossi B , SukalichS, DrozJet al.: Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.J. Clin. Endocrinol. Metab.93, 4780–4786(2008).
   PubMed Web of Science ®Google Scholar
• Bridger T , MacDonaldS, BaltzerF, RoddC: Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome.Arch. Pediatr. Adolesc. Med.160, 241–246(2006).
   PubMedGoogle Scholar
• Palmert MR , GordonCM, KartashovAI, LegroRS, EmansSJ, DunaifA: Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.J. Clin. Endocrinol. Metab.87, 1017–1023(2002).
   PubMed Web of Science ®Google Scholar
• Arslanian SA , LewyVD, DanadianK: Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease.J. Clin. Endocrinol. Metab.86, 66–71(2001).
   PubMed Web of Science ®Google Scholar
• Ibanez L , PotauN, MarcosMV, de Zegher F: Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide. J. Clin. Endocrinol. Metab.85, 3251–3255(2000).
   PubMed Web of Science ®Google Scholar
• Silfen ME , DenburgMR, ManiboAMet al.: Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.J. Clin. Endocrinol. Metab.88, 4682–4688(2003).
   PubMed Web of Science ®Google Scholar
• Saad R , GungorN, ArslanianS: Progression from normal glucose tolerance to Type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates.Pediatr. Diabetes6, 95–99(2005).
   PubMed Web of Science ®Google Scholar
• Legro RS , KunselmanAR, DunaifA: Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.Am. J. Med.111, 607–613(2001).
   PubMed Web of Science ®Google Scholar
• Demirel F , BideciA, CinazPet al.: Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.Clin. Endocrinol. (Oxf.)67, 129–134(2007).
   PubMed Web of Science ®Google Scholar
• Fruzzetti F , PeriniD, LazzariniV, ParriniD, GenazzaniAR: Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels.Fertil. Steril.92, 626–634(2009).
   PubMed Web of Science ®Google Scholar
• Pasquali R , GambineriA: Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.Ann. NY Acad. Sci.1092, 158–174(2006).
   PubMed Web of Science ®Google Scholar
• Barber TM , McCarthyMI, WassJA, FranksS: Obesity and polycystic ovary syndrome.Clin. Endocrinol. (Oxf.)65, 137–145(2006).
   PubMed Web of Science ®Google Scholar
• Sawathiparnich P , WeerakulwattanaL, SantiprabhobJ, LikitmaskulS: Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.J. Med. Assoc. Thai.88(Suppl. 8), S33–S37 (2005).
   PubMedGoogle Scholar
• Glueck CJ , MorrisonJA, FriedmanLA, GoldenbergN, StroopDM, WangP: Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.Metabolism55, 508–514(2006).
   PubMed Web of Science ®Google Scholar
• Kiddy DS , Hamilton-FairleyD, BushAet al.: Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.Clin. Endocrinol. (Oxf.)36, 105–111(1992).
   PubMed Web of Science ®Google Scholar
• Holte J , BerghT, BerneC, WideL, LithellH: Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.J. Clin. Endocrinol. Metab.80, 2586–2593(1995).
   PubMed Web of Science ®Google Scholar
• de Sousa G , SchluterB, BuschatzDet al.: A comparison of polysomnographic variables between obese adolescents with polycystic ovarian syndrome and healthy, normal-weight and obese adolescents.Sleep Breath DOI:10.1007/s11325-009-0276-0 (2009) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Moran LJ , BrinkworthGD, NormanRJ: Dietary therapy in polycystic ovary syndrome.Semin. Reprod. Med.26, 85–92(2008).
   PubMed Web of Science ®Google Scholar
• Hoeger KM , KochmanL, WixomN, CraigK, MillerRK, GuzickDS: A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.Fertil. Steril.82, 421–429(2004).
   PubMed Web of Science ®Google Scholar
• Hoeger K , DavidsonK, KochmanL, CherryT, KopinL, GuzickDS: The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials.J. Clin. Endocrinol. Metab.93, 4299–4306(2008).
   PubMed Web of Science ®Google Scholar
• Kasim-Karakas SE , AlmarioRU, CunninghamW: Effects of protein versus simple sugar intake on weight loss in polycystic ovary syndrome (according to the National Institutes of Health criteria).Fertil. Steril.92, 262–270(2009).
   PubMed Web of Science ®Google Scholar
• Moran LJ , NoakesM, CliftonPM, WittertGA, WilliamsG, NormanRJ: Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome.Am. J. Clin. Nutr.84, 77–87(2006).
   PubMed Web of Science ®Google Scholar
• Moran LJ , NoakesM, CliftonPM, TomlinsonL, GalletlyC, NormanRJ: Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome.J. Clin. Endocrinol. Metab.88, 812–819(2003).
   PubMed Web of Science ®Google Scholar
• Stamets K , TaylorDS, KunselmanA, DemersLM, PelkmanCL, LegroRS: A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome.Fertil. Steril.81, 630–637(2004).
   PubMed Web of Science ®Google Scholar
• Thomson RL , BuckleyJD, NoakesM, CliftonPM, NormanRJ, BrinkworthGD: The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.J. Clin. Endocrinol. Metab.93, 3373–3380(2008).
   PubMed Web of Science ®Google Scholar
• Moghetti P , ToscanoV: Treatment of hirsutism and acne in hyperandrogenism.Best Pract. Res. Clin. Endocrinol. Metab.20, 221–234(2006).
   PubMed Web of Science ®Google Scholar
• Azziz R : The evaluation and management of hirsutism.Obstet. Gynecol.101, 995–1007(2003).
   PubMed Web of Science ®Google Scholar
• Nouri K , VejjabhinantaV, PatelSS, SinghA: Photoepilation: a growing trend in laser-assisted cosmetic dermatology.J. Cosmet. Dermatol.7, 61–67(2008).
   PubMedGoogle Scholar
• Dawber RP : Guidance for the management of hirsutism.Curr. Med. Res. Opin.21, 1227–1234(2005).
   PubMed Web of Science ®Google Scholar
• Grippaudo FR , AngeliniM, ChiossiMR, ToscanoV: Intense pulsed light photoepilation in hirsute women: the role of obesity.Lasers Med. Sci.24, 415–418(2009).
   PubMed Web of Science ®Google Scholar
• Balfour JA , McClellanK: Topical eflornithine.Am. J. Clin. Dermatol.2, 197–201; discussion 202 (2001).
   PubMedGoogle Scholar
• Mathur R , LevinO, AzzizR: Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome.Ther. Clin. Risk Manag.4, 487–492(2008).
   PubMedGoogle Scholar
• Mishell DR Jr: YAZ and the novel progestin drospirenone. J. Reprod. Med.53, 721–728(2008).
   PubMed Web of Science ®Google Scholar
• van Vloten WA , van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R: The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis69, 2–15(2002).
   PubMedGoogle Scholar
• Archer JS , ChangRJ: Hirsutism and acne in polycystic ovary syndrome.Best Pract. Res. Clin. Obstet. Gynaecol.18, 737–754(2004).
   PubMed Web of Science ®Google Scholar
• Nappi C , FaraceMJ, LeoneF, MinutoloM, TommaselliAP, MontemagnoU: Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.Eur. J. Obstet. Gynecol. Reprod. Biol.25, 209–219(1987).
   PubMed Web of Science ®Google Scholar
• Lidegaard O : Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease.Br. J. Obstet. Gynaecol.102, 153–159(1995).
   PubMedGoogle Scholar
• Lloyd T , LinHM, MatthewsAE, BentleyCM, LegroRS: Oral contraceptive use by teenage women does not affect body composition.Obstet. Gynecol.100, 235–239(2002).
   PubMed Web of Science ®Google Scholar
• Mastorakos G , KoliopoulosC, DeligeoroglouE, Diamanti-KandarakisE, CreatsaG: Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome.Fertil. Steril.85, 420–427(2006).
   PubMed Web of Science ®Google Scholar
• Mastorakos G , KoliopoulosC, CreatsasG: Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.Fertil. Steril.77, 919–927(2002).
   PubMed Web of Science ®Google Scholar
• Yildiz BO : Oral contraceptives in polycystic ovary syndrome: risk-benefit assessment.Semin. Reprod. Med.26, 111–120(2008).
   PubMed Web of Science ®Google Scholar
• Ganie MA , KhuranaML, EuniceMet al.: Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study.J. Clin. Endocrinol. Metab.89, 2756–2762(2004).
   PubMed Web of Science ®Google Scholar
• Spritzer PM , LisboaKO, MattielloS, LhullierF: Spironolactone as a single agent for long-term therapy of hirsute patients.Clin. Endocrinol. (Oxf.)52, 587–594(2000).
   PubMed Web of Science ®Google Scholar
• Ibanez L , Lopez-BermejoA, DiazM, EnriquezG, del Rio L, de Zegher F: Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months. Clin. Endocrinol. (Oxf.)71, 351–357(2009).
   PubMed Web of Science ®Google Scholar
• Ibanez L , de Zegher F: Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women. Human Reproduction Update12, 243–252(2006).
   PubMed Web of Science ®Google Scholar
• Falsetti L , GamberaA, LegrenziL, IacobelloC, BugariG: Comparison of finasteride versus flutamide in the treatment of hirsutism.Eur. J. Endocrinol.141, 361–367(1999).
   PubMed Web of Science ®Google Scholar
• Practice Committee of the American Society for Reproductive Medicine: Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome. Fertil. Steril.90, S69–S73 (2008).
   PubMed Web of Science ®Google Scholar
• Tang T , LordJM, NormanRJ, YasminE, BalenAH: Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.Cochrane Database Syst. Rev.CD003053 (2009).
   Web of Science ®Google Scholar
• Arslanian SA , LewyV, DanadianK, SaadR: Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.J. Clin. Endocrinol. Metab.87, 1555–1559(2002).
   PubMed Web of Science ®Google Scholar
• La Marca A , ArtensioAC, StabileG, VolpeA: Metformin treatment of PCOS during adolescence and the reproductive period.Eur. J. Obstet. Gynecol. Reprod. Biol.121, 3–7(2005).
   PubMed Web of Science ®Google Scholar
• Ibanez L , FerrerA, OngK, AminR, DungerD, de Zegher F: Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J. Pediatr.144, 23–29(2004).
   PubMed Web of Science ®Google Scholar
• De Leo V , MusacchioMC, MorganteG, PiomboniP, PetragliaF: Metformin treatment is effective in obese teenage girls with PCOS.Hum. Reprod.21, 2252–2256(2006).
   PubMed Web of Science ®Google Scholar
• Glueck CJ , WangP, FontaineR, TracyT, Sieve-SmithL: Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).J. Adolesc. Health29, 160–169(2001).
   PubMed Web of Science ®Google Scholar
• Ibanez L , VallsC, FerrerA, MarcosMV, Rodriguez-HierroF, de Zegher F: Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism. J. Clin. Endocrinol. Metab.86, 3595–3598(2001).
   PubMed Web of Science ®Google Scholar
• Ibanez L , VallsC, PotauN, MarcosMV, de Zegher F: Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. J. Clin. Endocrinol. Metab.85, 3526–3530(2000).
   PubMed Web of Science ®Google Scholar
• Kashyap S , WellsGA, RosenwaksZ: Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome.Hum. Reprod.19, 2474–2483(2004).
   PubMed Web of Science ®Google Scholar
• Charles B , NorrisR, XiaoX, HagueW: Population pharmacokinetics of metformin in late pregnancy.Ther. Drug Monit.28, 67–72(2006).
   PubMed Web of Science ®Google Scholar
• Lehmann JM , MooreLB, Smith-OliverTA, WilkisonWO, WillsonTM, KliewerSA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR γ).J. Biol. Chem.270, 12953–12956(1995).
   PubMed Web of Science ®Google Scholar
• Froment P , TouraineP: Thiazolidinediones and fertility in polycystic ovary syndrome (PCOS).PPAR Res.2006, 73986 (2006).
   PubMed Web of Science ®Google Scholar
• Khan MA , St Peter JV, Xue JL: A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with Type 2 diabetes who were previously treated with troglitazone. Diabetes Care25, 708–711(2002).
   PubMed Web of Science ®Google Scholar
• Stener-Victorin E , JedelE, MannerasL: Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence.J. Neuroendocrinol.20, 290–298(2008).
   PubMed Web of Science ®Google Scholar
• Hou J , YuJ, WeiM: Study on treatment of hyperandrogenism and hyperinsulinism in polycystic ovary syndrome with Chinese herbal formula ‘tiangui fang’.Zhongguo Zhong Xi Yi Jie He Za Zhi20, 589–592(2000).
   PubMedGoogle Scholar
• Lau FC , BagchiM, SenCK, BagchiD: Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes.Mol. Cell Biochem.317, 1–10(2008).
   PubMed Web of Science ®Google Scholar
• Hummel M , StandlE, SchnellO: Chromium in metabolic and cardiovascular disease.Horm. Metab. Res.39, 743–751(2007).
   PubMed Web of Science ®Google Scholar
• Papaleo E , UnferV, BaillargeonJP, ChiuTT: Contribution of myo-inositol to reproduction.Eur. J. Obstet. Gynecol. Reprod. Biol.147, 120–123(2009).
   PubMed Web of Science ®Google Scholar
• Farquhar C , LilfordRJ, MarjoribanksJ, VandekerckhoveP: Laparoscopic ‘drilling’ by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.Cochrane Database Syst. Rev.CD001122 (2007).
   PubMed Web of Science ®Google Scholar

Website

• Medical eligibility criteria for contraceptive use. Third edition. 2004. www.who.int/reproductivehealth/publications/mec/index.htm
   Google Scholar